Obesity
Study links age-related belly fat to a newly identified fat-progenitor cell state
Iniulat ng AI Larawang ginawa ng AI Fact checked
Researchers at City of Hope report that aging can spur the emergence of an age-enriched population of adipose progenitor cells that is especially prone to generating new fat cells in abdominal white fat. The work, published in Science, points to a signaling pathway that may help drive midlife increases in belly fat and could become a future therapeutic target.
A new Gastroenterology commentary revisits the American Gastroenterological Association’s 2017 POWER framework, arguing that GLP-1 medicines should be integrated with endoscopic therapies, bariatric surgery and precision medicine to improve long-term obesity outcomes.
Iniulat ng AI Fact checked
Semaglutide was associated with a lower rate of bone fractures and greater reductions in body mass index among adults with type 2 diabetes, according to a retrospective analysis presented at the Endocrine Society’s ENDO 2026 meeting in Chicago.
An international meta-analysis slated for presentation at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (May 12–15) suggests that people who increase their walking to roughly 8,500 steps a day during a weight-loss program and sustain similar levels afterward may be less likely to regain weight.
Iniulat ng AI
Scientists have developed a hybrid obesity treatment that uses GLP-1 and GIP signals to deliver a metabolic enhancer directly into cells. Early tests in mice showed greater weight loss and better blood sugar control than standard therapies. The approach aims to reduce side effects by limiting the drug's action to targeted areas.
New research from Turkey shows that men with obesity tend to develop more abdominal fat and liver stress, while women exhibit higher inflammation and cholesterol levels. These findings, presented at the European Congress on Obesity in Istanbul, highlight sex-based differences that could inform personalized treatments. The study analyzed patients treated between 2024 and 2025.
Iniulat ng AI
Researchers at Vanderbilt Health discovered that both popular weight loss drugs and bariatric surgery significantly reduce fat mass while causing modest losses in fat-free mass, including muscle, in patients with obesity. The findings, based on over 3,000 patients, show improvements in overall body composition over 24 months. Maintaining this balance is crucial for long-term health, the study emphasizes.
France reimburses Mounjaro and Wegovy for severe obesity
June 14, 2026 20:36Study: Physical activity fell after some patients with obesity started GLP-1 drugs
June 14, 2026 11:51One in three South Koreans obese in 2024, data shows
May 31, 2026 08:57Intermittent energy restriction tied to shifts in brain activity and gut microbiome, small study suggests
May 30, 2026 03:23Tomato-soy juice reduces inflammation markers in adults with obesity
May 05, 2026 14:05Study finds people who use Ozempic-like drugs for weight loss face added stigma
April 25, 2026 05:27Young Indians risk health with Ozempic, Mounjaro for pre-wedding weight loss
April 23, 2026 17:51Gut reset procedure limits weight regain after stopping Ozempic
April 17, 2026 23:51Researchers map hindbrain circuit through which hormone FGF21 drives weight loss in obese mice
April 14, 2026 06:52Mice gain weight from bread without extra calories, study shows